Avecho Biotechnology Limited AI Stock Analysis
Avecho Biotechnology Limited (OEZ) AI Stock Analysis
Avecho Biotechnology Limited
(Frankfurt:OEZ)
No summary available
Avecho Biotechnology Limited (OEZ) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 46.36M
- Dividend Yield
- ―
- Average Volume (3M)
- 4,000
- Price to Earnings (P/E)
- -8.0
- Beta (1Y)
- 12.17
- Revenue Growth
- -49.58%
- EPS Growth
- 14.29%
- Country
- Germany
- Employees
- 9
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Biotechnology
Avecho Biotechnology Limited Business Overview & Revenue Model
Company Description
Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India. It operat...
Avecho Biotechnology Limited Peers Comparison
Overall Rating
AU:IMM50Neutral
AU:PAR47Neutral
AU:RCE46Neutral
AU:IMU40Underperform
AU:PTX40Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 50Neutral | AUD 38.33M | -0.45 | -98.86% | ― | ― | -27.73% | |
| 47Neutral | AUD 153.48M | -1.61 | -1189.87% | ― | 53.78% | -206.24% | |
| 46Neutral | AUD 114.72M | -7.24 | 84.67% | ― | ― | 42.51% | |
| 40Underperform | AUD 17.04M | -0.10 | -414.10% | ― | ― | -2.15% | |
| 40Underperform | AUD 62.91M | -7.97 | -44.93% | ― | ― | 25.27% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:OEZ | Avecho Biotechnology Limited | 0.01 | 0.00 | 0.00% | |
| AU:IMU | Imugene Ltd | 0.03 | -0.27 | -89.33% | |
| AU:PAR | Paradigm Biopharmaceuticals Ltd. | 0.24 | -0.08 | -24.62% | |
| AU:IMM | Immutep Ltd | 0.02 | -0.24 | -90.77% | |
| AU:PTX | Prescient Therapeutics Limited | 0.06 | 0.00 | 1.85% | |
| AU:RCE | Recce Pharmaceuticals Ltd. | 0.38 | -0.04 | -9.64% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
